BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29403003)

  • 1. Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis.
    Kim DH; Park HJ; Lim S; Koo JH; Lee HG; Choi JO; Oh JH; Ha SJ; Kang MJ; Lee CM; Lee CG; Elias JA; Choi JM
    Nat Commun; 2018 Feb; 9(1):503. PubMed ID: 29403003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitinase 3-like-1, a novel regulator of Th1/CTL responses, as a therapeutic target for increasing anti-tumor immunity.
    Kim DH; Choi JM
    BMB Rep; 2018 May; 51(5):207-208. PubMed ID: 29699605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses.
    Ma B; Akosman B; Kamle S; Lee CM; He CH; Koo JS; Lee CG; Elias JA
    J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIG-like Helicase Regulation of Chitinase 3-like 1 Axis and Pulmonary Metastasis.
    Ma B; Herzog EL; Moore M; Lee CM; Na SH; Lee CG; Elias JA
    Sci Rep; 2016 May; 6():26299. PubMed ID: 27198666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitinase 3-like-1 deficient donor splenocytes accentuated the pathogenesis of acute graft-versus-host diseases through regulating T cell expansion and type I inflammation.
    Li Z; Gu J; Liu J; Zhu Q; Lu H; Lu Y; Rao J; Lu L; Wang X
    Int Immunopharmacol; 2017 May; 46():201-209. PubMed ID: 28324830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor mechanism of Z-100, an immunomodulatory Arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, on pulmonary metastases of B16F10 melanoma: restoration of helper T cell responses via suppression of glucocorticoid-genesis.
    Oka H; Emori Y; Sasaki H; Shiraishi Y; Yoshinaga K; Kurimoto T
    Microbiol Immunol; 2002; 46(5):343-51. PubMed ID: 12139394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
    Kim KC; Yun J; Son DJ; Kim JY; Jung JK; Choi JS; Kim YR; Song JK; Kim SY; Kang SK; Shin DH; Roh YS; Han SB; Hong JT
    Theranostics; 2018; 8(16):4409-4428. PubMed ID: 30214629
    [No Abstract]   [Full Text] [Related]  

  • 8. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.
    Chaudhari AD; Gude RP; Kalraiya RD; Chiplunkar SV
    Mol Immunol; 2015 Dec; 68(2 Pt A):300-11. PubMed ID: 26442663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis.
    Ma B; Herzog EL; Lee CG; Peng X; Lee CM; Chen X; Rockwell S; Koo JS; Kluger H; Herbst RS; Sznol M; Elias JA
    Cancer Res; 2015 Feb; 75(3):487-96. PubMed ID: 25511377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory Th1 cells augment tumor-specific CTL following transcutaneous peptide immunization.
    Hosoi A; Takeda Y; Furuichi Y; Kurachi M; Kimura K; Maekawa R; Takatsu K; Kakimi K
    Cancer Res; 2008 May; 68(10):3941-9. PubMed ID: 18483280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHI3L1 enhances melanoma lung metastasis
    Ma B; Kamle S; Akosman B; Khan H; Lee CM; Lee CG; Elias JA
    Front Immunol; 2022; 13():1056397. PubMed ID: 36618349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis.
    Park KR; Yun HM; Yoo K; Ham YW; Han SB; Hong JT
    Cell Commun Signal; 2020 Mar; 18(1):5. PubMed ID: 32127023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakdown of Th cell immune responses and steroidogenic CYP11A1 expression in CD4+ T cells in a murine model implanted with B16 melanoma.
    Oka H; Emori Y; Hayashi Y; Nomoto K
    Cell Immunol; 2000 Nov; 206(1):7-15. PubMed ID: 11161433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy.
    Yang PS; Yu MH; Hou YC; Chang CP; Lin SC; Kuo IY; Su PC; Cheng HC; Su WC; Shan YS; Wang YC
    Theranostics; 2022; 12(1):340-361. PubMed ID: 34987649
    [No Abstract]   [Full Text] [Related]  

  • 15. Deletion of Chitinase-3-like 1 accelerates stroke development through enhancement of Neuroinflammation by STAT6-dependent M2 microglial inactivation in Chitinase-3-like 1 knockout mice.
    Im JH; Yeo IJ; Park PH; Choi DY; Han SB; Yun J; Hong JT
    Exp Neurol; 2020 Jan; 323():113082. PubMed ID: 31669069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation.
    Thomas MJ; Noble A; Sawicka E; Askenase PW; Kemeny DM
    J Immunol; 2002 Jan; 168(1):216-23. PubMed ID: 11751965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model.
    Libreros S; Garcia-Areas R; Shibata Y; Carrio R; Torroella-Kouri M; Iragavarapu-Charyulu V
    Int J Cancer; 2012 Jul; 131(2):377-86. PubMed ID: 21866546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-metastatic activity induced by the in vivo activation of purified protein derivative (PPD)-recognizing Th1 type CD4+ T cells.
    Shinomiya Y; Harada M; Kurosawa S; Okamoto T; Terao H; Matsuzaki G; Shirakusa T; Nomoto K
    Immunobiology; 1995 Aug; 193(5):439-55. PubMed ID: 8522359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.